Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

As some retail pharmacies have struggled to stay open, especially in diverse neighborhoods in Boston, community health centers are stepping up to fill the void.

Humana (HUM) won't be alone in cutting back on its Medicare Advantage offerings. Other insurers, including CVS (CVS) and Centene (CNC), have also warned that they are cutting back on lower-profit or ...

Truist analyst David MacDonald raised the firm’s price target on CVS Health (CVS) to $76 from $60 and keeps a Buy rating on the shares after ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

“We see the reward as positively skewed on a risk-adjusted basis,” analysts at Leerink Partners wrote, citing improving ...

Full Year 2024 Results Key Financial Results Revenue: US$372.8b (up 4.5% from FY 2023).

Adjusted EPS of $1.19 decreased from $2.12 in the prior year, beating the consensus of $0.93, primarily due to a decline in ...

CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...

We recently published a list of These 10 Stocks Led Rally on Wednesday. In this article, we are going to take a look at where CVS Health Corp.